Effects of drinking hydrogen-rich water on the quality of life of patients treated with radiotherapy for liver tumors.
Ki-Mun Kang, Young-Nam Kang, Ihil-Bong Choi, Yeunhwa Gu, Tomohiro Kawamura, Yoshiya Toyoda, Atsunori Nakao · Medical gas research · 2011
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In 49 patients, qOL scores during radiotherapy were significantly improved in patients treated with hydrogen-rich water compared to patients receiving placebo water.
What the Researchers Studied
This study examined whether hydrogen treatment, in the form of hydrogen-supplemented water, improved QOL in patients receiving radiotherapy.
How the Study Was Conducted
Randomized, placebo-controlled human clinical trial.
How Molecular Hydrogen Was Used
A randomized, placebo-controlled study was performed to evaluate the effects of drinking hydrogen-rich water on 49 patients receiving radiotherapy for malignant liver tumors. Hydrogen-rich water was produced by placing a metallic magnesium stick into drinking water (final hydrogen concentration; 0.55~0.65 mM).
What the Researchers Found
QOL scores during radiotherapy were significantly improved in patients treated with hydrogen-rich water compared to patients receiving placebo water.
Authors’ Conclusion
The authors concluded that daily consumption of hydrogen-rich water is a potentially novel, therapeutic strategy for improving QOL after radiation exposure.